healio.com
SAN DIEGO — Liver stiffness measurements may help predict the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease, as well as identify those in need of surveillance, according to data.
“MASLD is the commonest liver disease in the world and the fastest rising cause of liver cancer,” Binu John, MD, MPH, chief of
about 1 month ago